Gardai; Shyra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gardai; Shyra.The latest application filed is for "dosage and administration of non-fucosylated anti-cd40 antibody".

Company Profile

4.4.16

Gardai; Shyra - Bothell WA
Gardai; Shyra - Hayward CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibody App 20220265822 - Gardai; Shyra ; et al.	2022-08-25
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibodies App 20220249662 - Gardai; Shyra ; et al.	2022-08-11
Anti-TIGIT antibodies Grant 11,401,339 - Piasecki , et al. August 2, 2	2022-08-02
CD47 Antibodies and Uses Thereof for Treating Cancer App 20220135674 - Gardai; Shyra ; et al.	2022-05-05
Methods Of Treating Cancer With A Combination Of An Anti-pd-1 Antibody And An Anti-tissue Factor Antibody-drug Conjugate App 20220088191 - RANGWALA; Reshma Abdulla ; et al.	2022-03-24
Dosage and administration of non-fucosylated anti-CD40 antibodies Grant 11,213,584 - Gardai , et al. January 4, 2	2022-01-04
Dosage and administration of non-fucosylated anti-CD40 antibodies Grant 11,202,827 - Gardai , et al. December 21, 2	2021-12-21
CD47 antibodies and uses thereof for treating cancer Grant 11,180,552 - Gardai , et al. November 23, 2	2021-11-23
Methods Of Treating Cancer With Nonfucosylated Anti-cd70 Antibodies App 20210221897 - GARDAI; Shyra ; et al.	2021-07-22
Methods Of Treating Cancer With A Combination Of An Anti-pd-1 Antibody And An Anti-tissue Factor Antibody-drug Conjugate App 20210107980 - RANGWALA; Reshma Abdulla ; et al.	2021-04-15
Modulating The Immune Response Using Antibody-drug Conjugates App 20200239585 - HEISER; Ryan ; et al.	2020-07-30
T Cells With Reduced Surface Fucosylation And Methods Of Making And Using The Same App 20200149082 - OKELEY; Nicole ; et al.	2020-05-14
Anti-TIGIT Antibodies App 20200062859 - Piasecki; Julia C. ; et al.	2020-02-27
CD47 Antibodies and Uses Thereof for Treating Cancer App 20190185561 - Gardai; Shyra ; et al.	2019-06-20
Cancer Treatment Using 2-deoxy-2-fluoro-l-fucose In Combination With A Checkpoint Inhibitor App 20180353524 - Gardai; Shyra ; et al.	2018-12-13
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibodies App 20170333556 - Gardai; Shyra ; et al.	2017-11-23
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibodies App 20170137528 - Gardai; Shyra ; et al.	2017-05-18
C-terminal And Central Epitope A-beta Antibodies App 20150353631 - Buttini; Manuel ; et al.	2015-12-10
Phagocytic Activity As A Marker Of Synucleinopathic Disease App 20140186294 - Gardai; Shyra ; et al.	2014-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.